Novartis Pharmaceuticals Corp. is accused of offering kickbacks to a specialty pharmacy, BioScrip, in exchange for recommending refills of a blood transfusion drug it produces, according to a complaint filed by state and federal prosecutors in New York. According to New York Attorney General Eric T. Scheniderman, BioScrip agreed to pay $15 million to settle charges that it caused pharmacies to submit tens of thousands of false claims to Medicare and Medicaid. Read the full story